The Community of Madrid is promoting the Northern Industrial District, with Alcobendas as the main hub, specialising in pharmacy, biotechnology, and aerospace. The project aims to attract investments and generate qualified employment.
The municipality of Alcobendas will become the epicentre of the future Northern Industrial District, an initiative driven by the Community of Madrid as part of its 2026-2030 Industrial Plan. This strategic project will specialise in the pharmaceutical, biotechnology, and aerospace sectors, and aims to consolidate a high-value-added business ecosystem that attracts new national and international investments.
This has been announced by the regional government, which positions Alcobendas as the main hub of this initiative, alongside San Sebastián de los Reyes and Tres Cantos. The choice of these locations responds to their strong business and technological fabric, concentrated along the A-1 corridor, one of the main communication routes in the north of the Community of Madrid.
According to data from the Community of Madrid, Alcobendas is home to more than 16,000 companies and freelancers, with an annual turnover exceeding 77.5 billion euros. These figures place the municipality among the most economically active in Spain, thanks to the presence of multinational corporations, technological centres, and companies linked to research and development.
In the pharmaceutical and biotechnology sectors, companies such as Lilly, Italfarmaco, and Netpharma already have a presence in Alcobendas. The recent expansion of Italfarmaco, with an investment of 10 million euros to increase its production capacity, reinforces the growth trend of the sector in the area.
The Northern Industrial District includes a series of measures to facilitate the establishment of new companies. Among them are the creation of a single point of contact, training programmes tailored to the needs of the industry, and greater collaboration between companies, universities, and research centres. The goal is to promote technology transfer, boost innovation, and improve the competitiveness of a sector considered strategic for the Madrid economy.
The commitment to specialised training has already begun to materialise with projects such as the future Madrid Centre for Innovation and Employment Training in Tres Cantos, specifically aimed at the pharmaceutical and biotechnology sectors. This centre will help meet the growing demand for qualified professionals in the region.
With this strategy, Alcobendas aims to establish itself as one of the major national references in the pharmaceutical and biotechnology industry, enhancing its appeal for new investments and consolidating northern Madrid as one of Spain's main hubs for innovation and business development.
The 2026-2030 Industrial Plan of the Community of Madrid seeks, as a whole, to promote the reindustrialisation of the region, with special attention to high-value-added sectors. The Northern Industrial District is a key piece of this strategy, which aims to generate quality employment and attract talent and investment.
For the residents of Alcobendas and nearby municipalities, this project represents an opportunity for economic and labour development. The creation of new qualified jobs and the arrival of innovative companies can invigorate the local productive fabric and improve the quality of life in the area.
In the coming months, the Community of Madrid plans to present the specific details of the Northern Industrial District, including timelines and planned investments. Meanwhile, the companies already established in Alcobendas view this initiative positively, as it strengthens their strategic position in the north of the region.

